nodes	percent_of_prediction	percent_of_DWPC	metapath
Penciclovir—Liver function test abnormal—Teniposide—lymphatic system cancer	0.0168	0.0168	CcSEcCtD
Penciclovir—Erythema multiforme—Mechlorethamine—lymphatic system cancer	0.0161	0.0161	CcSEcCtD
Penciclovir—Liver function test abnormal—Fludarabine—lymphatic system cancer	0.0147	0.0147	CcSEcCtD
Penciclovir—Neutropenia—Teniposide—lymphatic system cancer	0.0147	0.0147	CcSEcCtD
Penciclovir—Toxic epidermal necrolysis—Fludarabine—lymphatic system cancer	0.0144	0.0144	CcSEcCtD
Penciclovir—Leukocytoclastic vasculitis—Methotrexate—lymphatic system cancer	0.0133	0.0133	CcSEcCtD
Penciclovir—Leukopenia—Mechlorethamine—lymphatic system cancer	0.0133	0.0133	CcSEcCtD
Penciclovir—Disorientation—Bleomycin—lymphatic system cancer	0.0131	0.0131	CcSEcCtD
Penciclovir—Neutropenia—Fludarabine—lymphatic system cancer	0.0129	0.0129	CcSEcCtD
Penciclovir—Unspecified disorder of skin and subcutaneous tissue—Mechlorethamine—lymphatic system cancer	0.0125	0.0125	CcSEcCtD
Penciclovir—Stevens-Johnson syndrome—Fludarabine—lymphatic system cancer	0.0122	0.0122	CcSEcCtD
Penciclovir—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.0118	0.0118	CcSEcCtD
Penciclovir—Skin disorder—Mechlorethamine—lymphatic system cancer	0.0117	0.0117	CcSEcCtD
Penciclovir—Hypoaesthesia—Fludarabine—lymphatic system cancer	0.011	0.011	CcSEcCtD
Penciclovir—Erythema multiforme—Fludarabine—lymphatic system cancer	0.0104	0.0104	CcSEcCtD
Penciclovir—Renal failure acute—Mitoxantrone—lymphatic system cancer	0.0103	0.0103	CcSEcCtD
Penciclovir—Anaemia—Teniposide—lymphatic system cancer	0.0101	0.0101	CcSEcCtD
Penciclovir—Leukopenia—Teniposide—lymphatic system cancer	0.00978	0.00978	CcSEcCtD
Penciclovir—Liver function test abnormal—Carmustine—lymphatic system cancer	0.00942	0.00942	CcSEcCtD
Penciclovir—Confusional state—Teniposide—lymphatic system cancer	0.00899	0.00899	CcSEcCtD
Penciclovir—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00891	0.00891	CcSEcCtD
Penciclovir—Anaemia—Fludarabine—lymphatic system cancer	0.00888	0.00888	CcSEcCtD
Penciclovir—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00873	0.00873	CcSEcCtD
Penciclovir—Leukopenia—Fludarabine—lymphatic system cancer	0.0086	0.0086	CcSEcCtD
Penciclovir—Pruritus—Mechlorethamine—lymphatic system cancer	0.00856	0.00856	CcSEcCtD
Penciclovir—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00828	0.00828	CcSEcCtD
Penciclovir—Neutropenia—Carmustine—lymphatic system cancer	0.00825	0.00825	CcSEcCtD
Penciclovir—Hypoaesthesia—Bleomycin—lymphatic system cancer	0.00805	0.00805	CcSEcCtD
Penciclovir—Confusional state—Fludarabine—lymphatic system cancer	0.0079	0.0079	CcSEcCtD
Penciclovir—Neutropenia—Vincristine—lymphatic system cancer	0.00787	0.00787	CcSEcCtD
Penciclovir—Vomiting—Mechlorethamine—lymphatic system cancer	0.00769	0.00769	CcSEcCtD
Penciclovir—Nervous system disorder—Fludarabine—lymphatic system cancer	0.00769	0.00769	CcSEcCtD
Penciclovir—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00767	0.00767	CcSEcCtD
Penciclovir—Neutropenia—Mitoxantrone—lymphatic system cancer	0.00767	0.00767	CcSEcCtD
Penciclovir—Rash—Mechlorethamine—lymphatic system cancer	0.00763	0.00763	CcSEcCtD
Penciclovir—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00762	0.00762	CcSEcCtD
Penciclovir—Feeling abnormal—Teniposide—lymphatic system cancer	0.00735	0.00735	CcSEcCtD
Penciclovir—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00729	0.00729	CcSEcCtD
Penciclovir—Skin discolouration—Methotrexate—lymphatic system cancer	0.00721	0.00721	CcSEcCtD
Penciclovir—Nausea—Mechlorethamine—lymphatic system cancer	0.00718	0.00718	CcSEcCtD
Penciclovir—Urticaria—Teniposide—lymphatic system cancer	0.00708	0.00708	CcSEcCtD
Penciclovir—Abdominal pain—Teniposide—lymphatic system cancer	0.00705	0.00705	CcSEcCtD
Penciclovir—Erythema—Bleomycin—lymphatic system cancer	0.00704	0.00704	CcSEcCtD
Penciclovir—Paraesthesia—Fludarabine—lymphatic system cancer	0.00704	0.00704	CcSEcCtD
Penciclovir—Hallucination—Carmustine—lymphatic system cancer	0.00702	0.00702	CcSEcCtD
Penciclovir—Hypoaesthesia—Carmustine—lymphatic system cancer	0.00702	0.00702	CcSEcCtD
Penciclovir—Fatigue—Fludarabine—lymphatic system cancer	0.00676	0.00676	CcSEcCtD
Penciclovir—Hallucination—Vincristine—lymphatic system cancer	0.00671	0.00671	CcSEcCtD
Penciclovir—Hypoaesthesia—Vincristine—lymphatic system cancer	0.00671	0.00671	CcSEcCtD
Penciclovir—Pain—Fludarabine—lymphatic system cancer	0.0067	0.0067	CcSEcCtD
Penciclovir—Hypersensitivity—Teniposide—lymphatic system cancer	0.00657	0.00657	CcSEcCtD
Penciclovir—Anaemia—Bleomycin—lymphatic system cancer	0.00651	0.00651	CcSEcCtD
Penciclovir—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00646	0.00646	CcSEcCtD
Penciclovir—Asthenia—Teniposide—lymphatic system cancer	0.0064	0.0064	CcSEcCtD
Penciclovir—Pruritus—Teniposide—lymphatic system cancer	0.00631	0.00631	CcSEcCtD
Penciclovir—Leukopenia—Bleomycin—lymphatic system cancer	0.0063	0.0063	CcSEcCtD
Penciclovir—Cardiac disorder—Vincristine—lymphatic system cancer	0.00625	0.00625	CcSEcCtD
Penciclovir—Mental disorder—Carmustine—lymphatic system cancer	0.00619	0.00619	CcSEcCtD
Penciclovir—Erythema—Carmustine—lymphatic system cancer	0.00615	0.00615	CcSEcCtD
Penciclovir—Diarrhoea—Teniposide—lymphatic system cancer	0.0061	0.0061	CcSEcCtD
Penciclovir—Mental disorder—Vincristine—lymphatic system cancer	0.0059	0.0059	CcSEcCtD
Penciclovir—Confusional state—Bleomycin—lymphatic system cancer	0.00579	0.00579	CcSEcCtD
Penciclovir—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00577	0.00577	CcSEcCtD
Penciclovir—Erythema—Mitoxantrone—lymphatic system cancer	0.00571	0.00571	CcSEcCtD
Penciclovir—Anaemia—Carmustine—lymphatic system cancer	0.00568	0.00568	CcSEcCtD
Penciclovir—Vomiting—Teniposide—lymphatic system cancer	0.00567	0.00567	CcSEcCtD
Penciclovir—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00563	0.00563	CcSEcCtD
Penciclovir—Asthenia—Fludarabine—lymphatic system cancer	0.00562	0.00562	CcSEcCtD
Penciclovir—Rash—Teniposide—lymphatic system cancer	0.00562	0.00562	CcSEcCtD
Penciclovir—Dermatitis—Teniposide—lymphatic system cancer	0.00562	0.00562	CcSEcCtD
Penciclovir—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.0056	0.0056	CcSEcCtD
Penciclovir—Headache—Teniposide—lymphatic system cancer	0.00559	0.00559	CcSEcCtD
Penciclovir—Pruritus—Fludarabine—lymphatic system cancer	0.00554	0.00554	CcSEcCtD
Penciclovir—Leukopenia—Carmustine—lymphatic system cancer	0.0055	0.0055	CcSEcCtD
Penciclovir—Anaemia—Vincristine—lymphatic system cancer	0.00542	0.00542	CcSEcCtD
Penciclovir—Diarrhoea—Fludarabine—lymphatic system cancer	0.00536	0.00536	CcSEcCtD
Penciclovir—Nausea—Teniposide—lymphatic system cancer	0.0053	0.0053	CcSEcCtD
Penciclovir—Anaemia—Mitoxantrone—lymphatic system cancer	0.00528	0.00528	CcSEcCtD
Penciclovir—Leukopenia—Vincristine—lymphatic system cancer	0.00525	0.00525	CcSEcCtD
Penciclovir—Paraesthesia—Bleomycin—lymphatic system cancer	0.00516	0.00516	CcSEcCtD
Penciclovir—Renal failure acute—Methotrexate—lymphatic system cancer	0.00512	0.00512	CcSEcCtD
Penciclovir—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00511	0.00511	CcSEcCtD
Penciclovir—Confusional state—Carmustine—lymphatic system cancer	0.00506	0.00506	CcSEcCtD
Penciclovir—Vomiting—Fludarabine—lymphatic system cancer	0.00498	0.00498	CcSEcCtD
Penciclovir—Rash—Fludarabine—lymphatic system cancer	0.00494	0.00494	CcSEcCtD
Penciclovir—Dermatitis—Fludarabine—lymphatic system cancer	0.00494	0.00494	CcSEcCtD
Penciclovir—Pain—Bleomycin—lymphatic system cancer	0.00491	0.00491	CcSEcCtD
Penciclovir—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00491	0.00491	CcSEcCtD
Penciclovir—Headache—Fludarabine—lymphatic system cancer	0.00491	0.00491	CcSEcCtD
Penciclovir—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00474	0.00474	CcSEcCtD
Penciclovir—Confusional state—Mitoxantrone—lymphatic system cancer	0.0047	0.0047	CcSEcCtD
Penciclovir—Nervous system disorder—Vincristine—lymphatic system cancer	0.0047	0.0047	CcSEcCtD
Penciclovir—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00469	0.00469	CcSEcCtD
Penciclovir—Nausea—Fludarabine—lymphatic system cancer	0.00466	0.00466	CcSEcCtD
Penciclovir—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00457	0.00457	CcSEcCtD
Penciclovir—Urticaria—Bleomycin—lymphatic system cancer	0.00457	0.00457	CcSEcCtD
Penciclovir—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00453	0.00453	CcSEcCtD
Penciclovir—Paraesthesia—Carmustine—lymphatic system cancer	0.0045	0.0045	CcSEcCtD
Penciclovir—Somnolence—Carmustine—lymphatic system cancer	0.00446	0.00446	CcSEcCtD
Penciclovir—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.00436	0.00436	CcSEcCtD
Penciclovir—Paraesthesia—Vincristine—lymphatic system cancer	0.0043	0.0043	CcSEcCtD
Penciclovir—Pain—Carmustine—lymphatic system cancer	0.00429	0.00429	CcSEcCtD
Penciclovir—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.00426	0.00426	CcSEcCtD
Penciclovir—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00423	0.00423	CcSEcCtD
Penciclovir—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00419	0.00419	CcSEcCtD
Penciclovir—Somnolence—Mitoxantrone—lymphatic system cancer	0.00415	0.00415	CcSEcCtD
Penciclovir—Feeling abnormal—Carmustine—lymphatic system cancer	0.00413	0.00413	CcSEcCtD
Penciclovir—Fatigue—Vincristine—lymphatic system cancer	0.00413	0.00413	CcSEcCtD
Penciclovir—Asthenia—Bleomycin—lymphatic system cancer	0.00412	0.00412	CcSEcCtD
Penciclovir—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.0041	0.0041	CcSEcCtD
Penciclovir—Pain—Vincristine—lymphatic system cancer	0.00409	0.00409	CcSEcCtD
Penciclovir—Pruritus—Bleomycin—lymphatic system cancer	0.00407	0.00407	CcSEcCtD
Penciclovir—Fatigue—Mitoxantrone—lymphatic system cancer	0.00402	0.00402	CcSEcCtD
Penciclovir—Pain—Mitoxantrone—lymphatic system cancer	0.00399	0.00399	CcSEcCtD
Penciclovir—Abdominal pain—Carmustine—lymphatic system cancer	0.00397	0.00397	CcSEcCtD
Penciclovir—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00392	0.00392	CcSEcCtD
Penciclovir—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00384	0.00384	CcSEcCtD
Penciclovir—Neutropenia—Methotrexate—lymphatic system cancer	0.00382	0.00382	CcSEcCtD
Penciclovir—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00381	0.00381	CcSEcCtD
Penciclovir—Abdominal pain—Vincristine—lymphatic system cancer	0.00379	0.00379	CcSEcCtD
Penciclovir—Urticaria—Mitoxantrone—lymphatic system cancer	0.0037	0.0037	CcSEcCtD
Penciclovir—Hypersensitivity—Carmustine—lymphatic system cancer	0.0037	0.0037	CcSEcCtD
Penciclovir—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00369	0.00369	CcSEcCtD
Penciclovir—Vomiting—Bleomycin—lymphatic system cancer	0.00365	0.00365	CcSEcCtD
Penciclovir—Rash—Bleomycin—lymphatic system cancer	0.00362	0.00362	CcSEcCtD
Penciclovir—Dermatitis—Bleomycin—lymphatic system cancer	0.00362	0.00362	CcSEcCtD
Penciclovir—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.00361	0.00361	CcSEcCtD
Penciclovir—Asthenia—Carmustine—lymphatic system cancer	0.0036	0.0036	CcSEcCtD
Penciclovir—Hypersensitivity—Vincristine—lymphatic system cancer	0.00353	0.00353	CcSEcCtD
Penciclovir—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.00345	0.00345	CcSEcCtD
Penciclovir—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00344	0.00344	CcSEcCtD
Penciclovir—Asthenia—Vincristine—lymphatic system cancer	0.00344	0.00344	CcSEcCtD
Penciclovir—Diarrhoea—Carmustine—lymphatic system cancer	0.00343	0.00343	CcSEcCtD
Penciclovir—Nausea—Bleomycin—lymphatic system cancer	0.00341	0.00341	CcSEcCtD
Penciclovir—Asthenia—Mitoxantrone—lymphatic system cancer	0.00335	0.00335	CcSEcCtD
Penciclovir—Dizziness—Carmustine—lymphatic system cancer	0.00332	0.00332	CcSEcCtD
Penciclovir—Diarrhoea—Vincristine—lymphatic system cancer	0.00328	0.00328	CcSEcCtD
Penciclovir—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00319	0.00319	CcSEcCtD
Penciclovir—Vomiting—Carmustine—lymphatic system cancer	0.00319	0.00319	CcSEcCtD
Penciclovir—Dizziness—Vincristine—lymphatic system cancer	0.00317	0.00317	CcSEcCtD
Penciclovir—Rash—Carmustine—lymphatic system cancer	0.00316	0.00316	CcSEcCtD
Penciclovir—Dermatitis—Carmustine—lymphatic system cancer	0.00316	0.00316	CcSEcCtD
Penciclovir—Headache—Carmustine—lymphatic system cancer	0.00314	0.00314	CcSEcCtD
Penciclovir—Erythema multiforme—Methotrexate—lymphatic system cancer	0.00309	0.00309	CcSEcCtD
Penciclovir—Vomiting—Vincristine—lymphatic system cancer	0.00304	0.00304	CcSEcCtD
Penciclovir—Cardiac disorder—Methotrexate—lymphatic system cancer	0.00303	0.00303	CcSEcCtD
Penciclovir—Rash—Vincristine—lymphatic system cancer	0.00302	0.00302	CcSEcCtD
Penciclovir—Dermatitis—Vincristine—lymphatic system cancer	0.00302	0.00302	CcSEcCtD
Penciclovir—Headache—Vincristine—lymphatic system cancer	0.003	0.003	CcSEcCtD
Penciclovir—Nausea—Carmustine—lymphatic system cancer	0.00298	0.00298	CcSEcCtD
Penciclovir—Vomiting—Mitoxantrone—lymphatic system cancer	0.00296	0.00296	CcSEcCtD
Penciclovir—Rash—Mitoxantrone—lymphatic system cancer	0.00294	0.00294	CcSEcCtD
Penciclovir—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00294	0.00294	CcSEcCtD
Penciclovir—Headache—Mitoxantrone—lymphatic system cancer	0.00292	0.00292	CcSEcCtD
Penciclovir—Mental disorder—Methotrexate—lymphatic system cancer	0.00286	0.00286	CcSEcCtD
Penciclovir—Erythema—Methotrexate—lymphatic system cancer	0.00285	0.00285	CcSEcCtD
Penciclovir—Nausea—Vincristine—lymphatic system cancer	0.00284	0.00284	CcSEcCtD
Penciclovir—Dysgeusia—Methotrexate—lymphatic system cancer	0.00279	0.00279	CcSEcCtD
Penciclovir—Nausea—Mitoxantrone—lymphatic system cancer	0.00277	0.00277	CcSEcCtD
Penciclovir—Anaemia—Methotrexate—lymphatic system cancer	0.00263	0.00263	CcSEcCtD
Penciclovir—Leukopenia—Methotrexate—lymphatic system cancer	0.00255	0.00255	CcSEcCtD
Penciclovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.00241	0.00241	CcSEcCtD
Penciclovir—Confusional state—Methotrexate—lymphatic system cancer	0.00234	0.00234	CcSEcCtD
Penciclovir—Nervous system disorder—Methotrexate—lymphatic system cancer	0.00228	0.00228	CcSEcCtD
Penciclovir—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.00227	0.00227	CcSEcCtD
Penciclovir—Skin disorder—Methotrexate—lymphatic system cancer	0.00226	0.00226	CcSEcCtD
Penciclovir—Paraesthesia—Methotrexate—lymphatic system cancer	0.00209	0.00209	CcSEcCtD
Penciclovir—Somnolence—Methotrexate—lymphatic system cancer	0.00207	0.00207	CcSEcCtD
Penciclovir—Fatigue—Methotrexate—lymphatic system cancer	0.002	0.002	CcSEcCtD
Penciclovir—Pain—Methotrexate—lymphatic system cancer	0.00199	0.00199	CcSEcCtD
Penciclovir—Feeling abnormal—Methotrexate—lymphatic system cancer	0.00191	0.00191	CcSEcCtD
Penciclovir—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.0019	0.0019	CcSEcCtD
Penciclovir—Urticaria—Methotrexate—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Penciclovir—Abdominal pain—Methotrexate—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Penciclovir—Hypersensitivity—Methotrexate—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Penciclovir—Asthenia—Methotrexate—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Penciclovir—Pruritus—Methotrexate—lymphatic system cancer	0.00164	0.00164	CcSEcCtD
Penciclovir—Diarrhoea—Methotrexate—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Penciclovir—Dizziness—Methotrexate—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Penciclovir—Vomiting—Methotrexate—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Penciclovir—Rash—Methotrexate—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Penciclovir—Dermatitis—Methotrexate—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Penciclovir—Headache—Methotrexate—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Penciclovir—Nausea—Methotrexate—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
